B. Riley Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

B. Riley Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58,430	Closed	-$1.99M	–	1467
2023 Q2	$1.99M	Buy	+58,430	New	+$1.84M	0.04%	373
2023 Q1	–	Sell	-7,499	Closed	-$212K	–	1524
2022 Q4	$212K	Sell	7,499 -672	-8%	-$21.3K	0.01%	1225
2022 Q3	$269K	Buy	+8,171	New	+$300K	0.01%	1068
2022 Q1	–	Sell	-7,285	Closed	-$447K	–	1387
2021 Q4	$447K	Sell	7,285 -6,410	-47%	-$443K	0.01%	877
2021 Q3	$1.04M	Sell	13,695 -2,965	-18%	-$249K	0.03%	510
2021 Q2	$1.54M	Buy	16,660 +963	+6%	+$81.9K	0.05%	402
2021 Q1	$1.4M	Buy	15,697 +5,142	+49%	+$510K	0.05%	396
2020 Q4	$985K	Buy	+10,555	New	+$841K	0.05%	337

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

B. Riley Wealth Advisors's ARKG Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 58,430 shares — an estimated $1.99M sold.

B. Riley Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $1.99M in Q2 2023. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

B. Riley Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
B. Riley Wealth Advisors sold 58,430 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $1.99M.
B. Riley Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
B. Riley Wealth Advisors's ARK Genomic Revolution ETF position peaked at $1.99M in Q2 2023.
286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.